A drug developed by a UVA Health scientist has not only stopped but reversed paralysis and vision loss in a mouse model of ...
A drug developed by a UVA Health scientist has not only stopped but reversed paralysis and vision loss in a mouse model of ...
NIH funded study shows modified HIV drug reverses vision loss and paralysis in multiple sclerosis model: Bethesda, Maryland Friday, September 25, 2026, 12:00 Hrs [IST] A new Natio ...
Multiple sclerosis (MS) has long been regarded as a disease with different subtypes such as "relapsing" or "progressive." An international study, published on August 20, 2025, in Nature Medicine under ...
The symptoms and pathophysiology of primary progressive multiple sclerosis (PPMS) differ from other forms. For instance, patients with PPMS tend to have more sensory symptoms, like weakness, than ...
Multiancestry genome-wide association analyses of multiple sclerosis integrated with single-cell, single-nucleus and spatial transcriptomics data yield insights into the cellular, spatial and temporal ...
To provide the right treatment for MS, it is important to know when the disease changes from relapsing-remitting to secondary progressive, a transition that is currently recognized on average three ...
Multiple sclerosis (MS) is an autoimmune disease that destroys the protective myelin covering around nerves. Every five minutes, someone is diagnosed with the disease around the world, adding to about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results